about
Adrenal incidentaloma imaging - the first steps in therapeutic managementRegular exercise prevents the development of hyperglucocorticoidemia via adaptations in the brain and adrenal glands in male Zucker diabetic fatty ratsScreening for Cushing's syndrome in obese patients.Factitious Cushing's syndrome masquerading as Cushing's disease.Prevalence of adrenal masses in Japanese patients with type 2 diabetes mellitus.The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.Cushing's syndrome: all variants, detection, and treatmentInhalational Steroids and Iatrogenic Cushing's SyndromeCushing's syndrome: epidemiology and developments in disease management.Cushing's surgery: Role of the anesthesiologist.A Case of Acute Aortic Dissection Type B Associated with Cushing's Syndrome.Is it worthwhile to screen patients with type 2 diabetes mellitus for subclinical Cushing's syndrome?Endogenous subclinical hypercortisolism: Diagnostic uncertainties and clinical implications.Routine Screening for Cushing's Syndrome Is Not Required in Patients Presenting with ObesityLack of significant association between type 2 diabetes mellitus with longitudinal change in diurnal salivary cortisol: the multiethnic study of atherosclerosis.Pitfalls in the diagnosis of Cushing's syndrome.Specificity of screening tests for Cushing's syndrome in an overweight and obese population.Management of diabetes mellitus in clinical practice.Concomitant medication use can confound interpretation of the combined dexamethasone-corticotropin releasing hormone test in Cushing's syndrome.The clinical significance of adrenal incidentalomas.Pros and cons of screening for occult Cushing syndrome.Subclinical Cushing's syndrome: definition and management.Do patients with type 2 diabetes mellitus have an increased prevalence of Cushing's syndrome?Glucose metabolism in patients with subclinical Cushing's syndrome.Clinical Endocrinology in the near future: a post-modern challenge.Screening for Cushing's syndrome: is it worthwhile?Incidence of Cushing's syndrome and Cushing's disease in commercially-insured patients <65 years old in the United States.Discovery of Cushing's Syndrome After Bariatric Surgery: Multicenter Series of 16 Patients.Recommendations of the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism for the diagnosis of Cushing's disease in Brazil.Low positive predictive value of midnight salivary cortisol measurement to detect hypercortisolism in type 2 diabetes.Weekly clodronate treatment prevents bone loss and vertebral fractures in women with subclinical Cushing's syndrome.Prevalence of endocrine disorders in morbidly obese patients and the effects of bariatric surgery on endocrine and metabolic parameters.Elevated late-night salivary cortisol levels in elderly male type 2 diabetic veterans.Role of adrenal gland scintigraphy in patients with subclinical hypercortisolism and incidentally discovered adrenal mass.Hypothalamic paraventricular nucleus, but not vasopressin, participates in chronic hyperactivity of the HPA axis in diabetic rats.[Subclinical Cushing's syndrome in populations at risk].Overweight and metabolic and hormonal parameter disruption are induced in adult male mice by manipulations during lactation period.Impact of hypercortisolism on skeletal muscle mass and adipose tissue mass in patients with adrenal adenomas.Serum but not salivary cortisol levels are influenced by daily glycemic oscillations in type 2 diabetes.Relationship between type 2 diabetes mellitus and hypothalamic-pituitary-adrenal axis.
P2860
Q26862481-85974D94-BA60-429D-AAE9-52854C325487Q28575844-FDF9FD6D-F5EF-4071-9801-A8E8D5F5395AQ33626037-50597185-1426-431A-8BD1-30F61C151EC5Q34376630-7262BC00-85C3-46B7-AEFE-6D0A38F71AAAQ34478141-CAFD1AC1-725B-49E6-9A12-3AC15CB4BA19Q34760816-54F35C62-62BA-49B4-B5DC-F3784DF6BB10Q34984042-FD73381A-00E9-4F7B-A7A5-A6BD99E64E22Q35056151-E26077AB-C345-4941-BF30-C9BA55140751Q35531889-298B5155-3115-4C77-A27C-BB991DD670CCQ35590936-0D9F0896-0A42-4C0F-A576-1E108D11F54BQ35868524-6E5911CB-CFDA-4111-A1BA-AF9AA6DAE5A8Q36209847-0D59BE2F-CC2B-45B1-8FF1-BAA36EC4B854Q36516174-964545FF-F8DF-498E-8D4E-34AEA00E86F5Q36956000-AACDDA2F-72B0-4BD6-A226-ECD8F09C89A0Q36993893-A8C9C959-BA0C-4DF9-9481-5156836B7E4AQ37062023-E335B1FC-A3A3-42F0-BDA6-CDAAA74616C1Q37379514-72C017EB-470E-48EA-823F-F1E67BEE6DD8Q37383177-2BA079F6-1A9B-49FA-A1B7-A67E34047F01Q37482761-DBFADA74-8328-4899-8B9B-D0C72E4BC99DQ37826439-9B29005D-B9C8-41B7-A1F7-4EB3334BE0B1Q37855520-E66B7271-52BB-4852-8AF9-0A93CD59AA20Q37944294-A4321B84-25FC-4F67-8FA6-CCF1BCF42CA6Q37967615-F176EF6F-92F1-487E-A96A-E6CE16907FBBQ37990759-6F906F6E-A7A8-49A1-ABEF-3AA6EB1E92DEQ38255736-B1C7BF87-C138-43BF-9090-40DFE5684561Q38314145-03C22BEB-A0B7-4A17-A1E7-4CDBB9397433Q38420825-9D622475-85BC-424E-B7F8-16AC8AC3524EQ38445603-6CBD2AD3-9253-4741-B950-777C133B7217Q40632126-97662B1E-148E-4FEA-A11C-5F434ED3E084Q40827243-8F006BE1-E6A7-4D05-ACF1-EA22AE92FB9DQ43268923-BC168B51-65DF-4B6B-B8F9-95B605B8FCF7Q44800632-28363AF9-5D98-46D8-8ED0-1F22A8E27DD1Q45332911-92E8DCA0-0C32-4A0D-956F-5A97E94073BDQ45964750-7DE38F0F-4B41-4ABA-947B-B359B7574469Q46689280-3F45BB0E-E401-4524-B794-B8BFAE71B646Q46798187-1D19953C-3B59-4669-AC6F-26E22AF5B8D6Q46834991-51A2341A-D90A-437F-A925-985345BE3472Q48345771-B26FDAB3-29F5-4E02-B97D-CF2909238F81Q51294866-9B0DF94B-2472-4661-94D1-572FB73D88ACQ51623907-07C52558-61B0-4B6B-BACA-B11B761E018D
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Occult Cushing's syndrome in type-2 diabetes.
@en
Occult Cushing's syndrome in type-2 diabetes.
@nl
type
label
Occult Cushing's syndrome in type-2 diabetes.
@en
Occult Cushing's syndrome in type-2 diabetes.
@nl
prefLabel
Occult Cushing's syndrome in type-2 diabetes.
@en
Occult Cushing's syndrome in type-2 diabetes.
@nl
P2093
P356
P1476
Occult Cushing's syndrome in type-2 diabetes.
@en
P2093
Agathe Poussin
Antoine Tabarin
Bogdan Catargi
Nathalie Ronci-Chaix
Patrick Roger
Veronique Bex
Vincent Rigalleau
Vincent Vergnot
P304
P356
10.1210/JC.2003-030254
P407
P577
2003-12-01T00:00:00Z